Selected research
Industry Research
Anti-Nausea and Vomiting Healthcare Device Industry Research Report 2026
Market perspective
The global Anti-Nausea and Vomiting Healthcare Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Anti-Nausea and Vomiting Healthcare Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Anti-Nausea and Vomiting Healthcare Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Anti-Nausea and Vomiting Healthcare Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Anti-Nausea and Vomiting Healthcare Device include Blisslets, Dramamine(Prestige Consumer Healthcare), EmeTerm (WAT Medical), GRAVOL, MotionCure (Sidis Labs), NoMo, Psi Bands, Quease EASE (Soothing Scents) and Reliefband, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Anti-Nausea and Vomiting Healthcare Device market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-Nausea and Vomiting Healthcare Device Market by Company
Blisslets
Dramamine(Prestige Consumer Healthcare)
EmeTerm (WAT Medical)
GRAVOL
MotionCure (Sidis Labs)
NoMo
Psi Bands
Quease EASE (Soothing Scents)
Reliefband
Sea-Bands
Toulifly
Walgreens
Anti-Nausea and Vomiting Healthcare Device Segment by Type
Inhaler
Wrist Band
Food
Others
Anti-Nausea and Vomiting Healthcare Device Segment by Application
For Children
For Pregnant
For other people with motion sickness
Anti-Nausea and Vomiting Healthcare Device Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Nausea and Vomiting Healthcare Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Nausea and Vomiting Healthcare Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Nausea and Vomiting Healthcare Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Anti-Nausea and Vomiting Healthcare Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Anti-Nausea and Vomiting Healthcare Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Anti-Nausea and Vomiting Healthcare Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inhaler
- Wrist Band
- Food
- Others
Applications
- For Children
- For Pregnant
- For other people with motion sickness
Companies covered
- Blisslets
- Dramamine(Prestige Consumer Healthcare)
- EmeTerm (WAT Medical)
- GRAVOL
- MotionCure (Sidis Labs)
- NoMo
- Psi Bands
- Quease EASE (Soothing Scents)
- Reliefband
- Sea-Bands
- Toulifly
- Walgreens
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size (2021-2032)
- 2.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales (2021-2032)
- 2.2.3 Global Anti-Nausea and Vomiting Healthcare Device Market Average Price (2021-2032)
- 2.3 Anti-Nausea and Vomiting Healthcare Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inhaler
- 2.3.3 Wrist Band
- 2.3.4 Food
- 2.3.5 Others
- 2.4 Anti-Nausea and Vomiting Healthcare Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 For Children
- 2.4.3 For Pregnant
- 2.4.4 For other people with motion sickness
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Anti-Nausea and Vomiting Healthcare Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Anti-Nausea and Vomiting Healthcare Device Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Anti-Nausea and Vomiting Healthcare Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Anti-Nausea and Vomiting Healthcare Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Anti-Nausea and Vomiting Healthcare Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Anti-Nausea and Vomiting Healthcare Device, Product Type & Application
- 3.8 Global Manufacturers of Anti-Nausea and Vomiting Healthcare Device, Established Date
- 3.9 Global Anti-Nausea and Vomiting Healthcare Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Blisslets
- 4.1.1 Blisslets Company Information
- 4.1.2 Blisslets Business Overview
- 4.1.3 Blisslets Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Blisslets Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.1.5 Blisslets Recent Developments
- 4.2 Dramamine(Prestige Consumer Healthcare)
- 4.2.1 Dramamine(Prestige Consumer Healthcare) Company Information
- 4.2.2 Dramamine(Prestige Consumer Healthcare) Business Overview
- 4.2.3 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dramamine(Prestige Consumer Healthcare) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.2.5 Dramamine(Prestige Consumer Healthcare) Recent Developments
- 4.3 EmeTerm (WAT Medical)
- 4.3.1 EmeTerm (WAT Medical) Company Information
- 4.3.2 EmeTerm (WAT Medical) Business Overview
- 4.3.3 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 EmeTerm (WAT Medical) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.3.5 EmeTerm (WAT Medical) Recent Developments
- 4.4 GRAVOL
- 4.4.1 GRAVOL Company Information
- 4.4.2 GRAVOL Business Overview
- 4.4.3 GRAVOL Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GRAVOL Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.4.5 GRAVOL Recent Developments
- 4.5 MotionCure (Sidis Labs)
- 4.5.1 MotionCure (Sidis Labs) Company Information
- 4.5.2 MotionCure (Sidis Labs) Business Overview
- 4.5.3 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MotionCure (Sidis Labs) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.5.5 MotionCure (Sidis Labs) Recent Developments
- 4.6 NoMo
- 4.6.1 NoMo Company Information
- 4.6.2 NoMo Business Overview
- 4.6.3 NoMo Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 NoMo Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.6.5 NoMo Recent Developments
- 4.7 Psi Bands
- 4.7.1 Psi Bands Company Information
- 4.7.2 Psi Bands Business Overview
- 4.7.3 Psi Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Psi Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.7.5 Psi Bands Recent Developments
- 4.8 Quease EASE (Soothing Scents)
- 4.8.1 Quease EASE (Soothing Scents) Company Information
- 4.8.2 Quease EASE (Soothing Scents) Business Overview
- 4.8.3 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Quease EASE (Soothing Scents) Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.8.5 Quease EASE (Soothing Scents) Recent Developments
- 4.9 Reliefband
- 4.9.1 Reliefband Company Information
- 4.9.2 Reliefband Business Overview
- 4.9.3 Reliefband Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Reliefband Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.9.5 Reliefband Recent Developments
- 4.10 Sea-Bands
- 4.10.1 Sea-Bands Company Information
- 4.10.2 Sea-Bands Business Overview
- 4.10.3 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sea-Bands Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.10.5 Sea-Bands Recent Developments
- 4.11 Toulifly
- 4.11.1 Toulifly Company Information
- 4.11.2 Toulifly Business Overview
- 4.11.3 Toulifly Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Toulifly Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.11.5 Toulifly Recent Developments
- 4.12 Walgreens
- 4.12.1 Walgreens Company Information
- 4.12.2 Walgreens Business Overview
- 4.12.3 Walgreens Anti-Nausea and Vomiting Healthcare Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Walgreens Anti-Nausea and Vomiting Healthcare Device Product Portfolio
- 4.12.5 Walgreens Recent Developments
5 Global Anti-Nausea and Vomiting Healthcare Device Market Scenario by Region
- 5.1 Global Anti-Nausea and Vomiting Healthcare Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021-2032
- 5.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2021-2026
- 5.2.2 Global Anti-Nausea and Vomiting Healthcare Device Sales by Region: 2027-2032
- 5.3 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region: 2021-2032
- 5.3.1 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region: 2021-2026
- 5.3.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Region: 2027-2032
- 5.4 North America Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
- 5.4.1 North America Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
- 5.4.3 North America Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
- 5.5.1 Europe Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
- 5.5.3 Europe Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
- 5.7.1 South America Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
- 5.7.3 South America Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Anti-Nausea and Vomiting Healthcare Device Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032)
- 6.1.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Type (2021-2032)
- 6.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Type (2021-2032)
- 6.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Anti-Nausea and Vomiting Healthcare Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032)
- 7.1.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Anti-Nausea and Vomiting Healthcare Device Sales Market Share by Application (2021-2032)
- 7.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue by Application (2021-2032)
- 7.2.1 Global Anti-Nausea and Vomiting Healthcare Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Anti-Nausea and Vomiting Healthcare Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Anti-Nausea and Vomiting Healthcare Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Anti-Nausea and Vomiting Healthcare Device Value Chain Analysis
- 8.1.1 Anti-Nausea and Vomiting Healthcare Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Anti-Nausea and Vomiting Healthcare Device Production Mode & Process
- 8.2 Anti-Nausea and Vomiting Healthcare Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Anti-Nausea and Vomiting Healthcare Device Distributors
- 8.2.3 Anti-Nausea and Vomiting Healthcare Device Customers
9 Global Anti-Nausea and Vomiting Healthcare Device Analyzing Market Dynamics
- 9.1 Anti-Nausea and Vomiting Healthcare Device Industry Trends
- 9.2 Anti-Nausea and Vomiting Healthcare Device Industry Drivers
- 9.3 Anti-Nausea and Vomiting Healthcare Device Industry Opportunities and Challenges
- 9.4 Anti-Nausea and Vomiting Healthcare Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst